Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Riparian Pharmaceuticals

Riparian Pharmaceuticals
2012 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$500K LATEST DEAL AMOUNT
9 INVESTORS
Description

Developer of a medical therapy designed to treat cardiovascular and inflammatory diseases. The company's therapy helps physicians to treat cardiovascular diseases, reduce vascular inflammation and reverse endothelial dysfunction, enabling them to treat patients effectively.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Primary Office
  • 127 Western Avenue
  • Boston, MA 02134
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Riparian Pharmaceuticals’s full profile, request a free trial.

Riparian Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Early Stage VC (Series A) 12-Oct-2018 $500K 00000 00.00 Completed Startup
8. Accelerator/Incubator 05-Oct-2017 Completed Startup
7. Accelerator/Incubator 13-Oct-2016 Completed Startup
6. Accelerator/Incubator Completed Startup
5. Grant 06-Jun-2016 00000 Completed Startup
4. Grant 01-Jan-2016 00.000 Completed Startup
3. Grant 01-Jan-2016 00000 Completed Startup
2. Grant 16-Oct-2015 $200K Completed Startup
1. Grant 01-Jan-2013 $857K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Riparian Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 0.000
To view this company’s complete Cap Table, request access »

Riparian Pharmaceuticals Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JMCR Partners Venture Capital Minority 000 0000 000000 0
Sprout Bioventures Venture Capital Minority 000 0000 000000 0
Harvard Innovation Launch Lab Accelerator/Incubator 000 0000 000000 0
Pagliuca Harvard Life Lab Accelerator/Incubator 000 0000 000000 0
Janssen Research and Development Corporation 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Riparian Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
William Adams Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Guillermo Garcia-Cardena Ph.D Co-Founder & Scientific Advisor

Riparian Pharmaceuticals Board Members (2)

Name Representing Role Since Contact
Info
Michael Serrano-Wu Riparian Pharmaceuticals Board Member 000 0000
William Adams Ph.D Riparian Pharmaceuticals Co-Founder, President, Chief Executive Officer & Board Member 000 0000